Dannah Raz, MD, MPH, Named to Modern Healthcare’s 40 Under 40
-
April 9, 2026
-
3 min
April 9, 2026
Researchers proposed a new autism spectrum disorder phenotype characterized by elevated urinary microbially derived metabolites.
July 14, 2026
Phase 3 SUNRISE trial evaluates whether patients with severe asthma can taper maintenance oral corticosteroids while maintaining asthma control.
June 25, 2026
The device was previously cleared for adults aged 18 years and older in March 2024.
June 15, 2026